Brought to you by 
GSK acquires Bristol-Myers Squibb Pakistan for $36.5mm
01 Jun 2016
Executive Summary
In their second transaction this year covering emerging markets, BMS has sold its Bristol-Myers Squibb Pakistan Ltd. division to GlaxoSmithKline for $36.5mm.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Divestiture/Spin-Out
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
GSK acquires Bristol-Myers Squibb Pakistan for $36.5mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice